Business Card for Laura Barton:


Commercial Business Director, Diabetes ...
 Philadelphia, PA area
Email Avail: 3 Day Free Trial


1 Francis Crick Avenue
Cambridge, Cambridgeshire CB2 0AA
Tel: (800) 236-9933

Last updated on 2018-03-08

About Laura Barton:

Laura Barton works as an Commercial Business Director, Diabetes ... for AstraZeneca at Philadelphia, PA. The company's webpage is http://www.astrazeneca.com. For email, phone number and executive profiles for Commercial Business Director, Diabetes ... and other executives of AstraZeneca at Philadelphia, PA, check AstraZeneca at Joesdata.com. Not the Laura Barton you are looking for? Do a quick search in our website and find other people named Laura Barton.
Laura Barton's Work History:
Brand Manager at SYMBICORT
Promotions Manager at ASTRAZENCECA
LP Professional
Field Readiness Leader at CNS
Customer Alignment Manager at Mid- Atlantic Business Center
District Sales Manager at CNS Specialty Care
Pharmaceutical Sales Specialist at CNS Specialty Care
Pharmaceutical Sales Specialist
Respiratory/Cardiovascular at ASTRAZENCECA
LP Professional
Program Coordinator at Apple Underwriters
Account Manager at PHILIP J. HARVEY & CO.
INC
Account Representative at Philip J Harvey and Company
Account Executive at OFFICE CONSULTANTS
INC.

Laura Barton's Education:
Widener University
Widener University.

Laura Barton's Co-workers:
As of May 16, 2022, Laura Barton has 245 co-workers under the company name AstraZeneca at Joesdata.com.

About AstraZeneca:

AstraZeneca is located at 1 Francis Crick Avenue, Cambridge, Cambridgeshire CB2 0AA. It has over 10K employees. Its revenue is over $1B.

Company News:
2017-11-14 19:18:44
Faslodex (Fulvestrant) Receives EU Approval for the Treatment of Hormone Receptor-Positive Advanced Breast Cancer in Combination with Palbociclib1
2017-11-14 17:30:34
Faslodex (Fulvestrant) Receives EU Approval for the Treatment of Hormone Receptor-Positive Advanced Breast Cancer in Combination with Palbociclib1
2017-06-06 19:24:34
AstraZeneca Presents Tagrisso (osimertinib) Data in Patients with EGFR T790M-Mutation Positive Lung Cancer and Central Nervous System Metastases
2017-03-31 17:42:26
First Collaborative Definition of Patient Centricity, Co-created by AstraZeneca with Patients and Carers, Is Published in British Medical Journal
2017-03-31 17:30:25
First Collaborative Definition of Patient Centricity, Co-created by AstraZeneca with Patients and Carers, Is Published in British Medical Journal
2016-10-08 18:06:12
Faslodex Demonstrates Progression-Free Survival Advantage in 1st Line Advanced Breast Cancer
2016-10-08 17:30:18
Faslodex Demonstrates Progression-Free Survival Advantage in 1st Line Advanced Breast Cancer
2016-07-01 16:28:17
Foundation Medicine and AstraZeneca Enter Strategic Collaboration for Lynparza Companion Diagnostic Assay